Spire Healthcare’s shares staged a dramatic rally on Thursday, May 14, 2026. The stock surged 43.3% to 215.5 pence after second-largest shareholder Toscafund Asset Management put forward a non-binding takeover proposal. The offer values the UK private hospital operator at roughly £1 billion, or approximately $1.35 billion. This development marks one of the most significant moves in UK private healthcare M&A this year.
Overview of the Toscafund Takeover Proposal
Toscafund is already a major stakeholder in Spire Healthcare. Its proposal, submitted on May 14, signals a desire to take full control of the group. Importantly, the offer is non-binding at this stage. That means no deal is final yet. However, the terms are clear enough to have triggered a market-moving reaction within hours of the announcement.
Who Is Toscafund?
Toscafund Asset Management is a London-based hedge fund and asset manager with a track record of long-term investments in healthcare and financial services. As Spire Healthcare’s second-largest shareholder, Toscafund already holds a significant stake. This background gives the proposal added credibility in the eyes of investors and analysts.
Spire Healthcare Share Price Reaction
Spire Healthcare shares hit 215.5 pence during Thursday’s trading session. That represents a 43.3% single-day gain. Furthermore, the price reached its highest level since September 2025. Clearly, the market responded with strong conviction to the news. Trading volumes also spiked considerably, reflecting broad investor interest in the potential deal.
Context for the Share Price Movement
Before the announcement, Spire Healthcare shares had been trading under pressure for several months. Consequently, the 43% jump on Thursday represents a sharp reversal of recent trends. In addition, the proposed offer price of 250 pence per share carries a significant premium over recent trading levels, making it attractive to existing shareholders.
Terms of the Proposed Cash Offer
Toscafund has proposed a non-binding cash offer of 250 pence per share. At that price, the total transaction values Spire Healthcare at approximately £1 billion. The offer is an all-cash proposal, which provides shareholders with certainty of value. Moreover, the premium embedded in the 250 pence offer justifies the sharp share price move seen in early trading.
Non-Binding Nature of the Offer
It is important to note that the proposal is non-binding at this stage. Therefore, the deal is not yet legally committed. Toscafund must still convert this into a formal offer under the UK Takeover Code. Until then, the terms may change. Nevertheless, the board’s positive response suggests a firm offer could follow.
Board Response and Recommendation
Spire Healthcare’s board has responded constructively to the proposal. The board stated it would be minded to unanimously recommend the offer, provided Toscafund proceeds with a firm proposal on these exact terms. This is a notable development. Board recommendations carry significant weight with institutional shareholders. Thus, the board’s supportive stance greatly increases the likelihood that a formal deal will be completed.
Significance of Board Support
A board that unanimously backs an offer sends a strong signal to the market. It suggests the directors believe 250 pence per share represents fair value for shareholders. Additionally, unanimous backing reduces the risk of internal dissent derailing negotiations. For Toscafund, securing board support at this early stage is a key advantage as it moves toward a firm offer.
Deadline and Next Steps for Toscafund
Under UK Takeover Panel rules, Toscafund must act within a defined window. Specifically, the fund has until June 11, 2026, to either announce a firm intention to proceed with the acquisition or formally withdraw from the process. This deadline creates a clear timeline for investors. Moreover, it introduces a degree of urgency into negotiations. Market participants will now watch closely for any further announcements ahead of that date.
Regulatory Framework Under UK Takeover Code
UK takeover rules are designed to protect shareholders and ensure fair dealing. The Takeover Panel sets strict deadlines to prevent prolonged uncertainty. As a result, both Toscafund and Spire Healthcare must operate within this regulated framework. Any material developments before June 11 could trigger further share price moves. Investors should therefore monitor official announcements closely.
What This Means for Spire Healthcare Investors
The Toscafund proposal introduces both opportunity and uncertainty for Spire Healthcare shareholders. On one hand, the 250 pence offer represents a significant premium. On the other hand, the deal is not yet firm. Shareholders who bought at lower prices stand to benefit considerably if a firm offer materialises. However, investors should note that deals at this stage do not always complete. Careful monitoring of the process remains essential.
